Medical Care
Global G6PD Antibody Market Research Report 2025
- May 12, 25
- ID: 236049
- Pages: 104
- Figures: 108
- Views: 8
The global market for G6PD Antibody was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
G6PD Antibody (G-12) is an IgG1 κ mouse monoclonal G6PD antibody (also designated Glucose-6-Phosphate 1-Dehydrogenase antibody, or G6PD1 antibody) that detects the G6PD protein of human origin by WB, IP, IF, IHC(P) and ELISA.
North American market for G6PD Antibody is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for G6PD Antibody is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for G6PD Antibody in Immunochemistry (IHC) is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of G6PD Antibody include Merck, IBL, GeneTex, Aviva Systems Biology, LifeSpan BioSciences, RayBiotech, NSJ Bioreagents, ProSci, Abnova Corporation, Bethyl Laboratories, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for G6PD Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding G6PD Antibody.
The G6PD Antibody market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global G6PD Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the G6PD Antibody companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
IBL
GeneTex
Aviva Systems Biology
LifeSpan BioSciences
RayBiotech
NSJ Bioreagents
ProSci
Abnova Corporation
Bethyl Laboratories
Cell Signaling Technology
Leading Biology
Thermo Fisher Scientific
OriGene Technologies
ABclonal Technology
Proteintech Group
Sino Biological
Abcam
United States Biological
Biobyt
Jingjie PTM BioLab
Wuhan Fine
Segment by Type
Monoclonal
Polyclonal
Segment by Application
Immunochemistry (IHC)
Immunofluorescence (IF)
Immunoprecipitation (IP)
Western Blot (WB)
ELISA
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of G6PD Antibody company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
G6PD Antibody (G-12) is an IgG1 κ mouse monoclonal G6PD antibody (also designated Glucose-6-Phosphate 1-Dehydrogenase antibody, or G6PD1 antibody) that detects the G6PD protein of human origin by WB, IP, IF, IHC(P) and ELISA.
North American market for G6PD Antibody is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for G6PD Antibody is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for G6PD Antibody in Immunochemistry (IHC) is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of G6PD Antibody include Merck, IBL, GeneTex, Aviva Systems Biology, LifeSpan BioSciences, RayBiotech, NSJ Bioreagents, ProSci, Abnova Corporation, Bethyl Laboratories, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for G6PD Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding G6PD Antibody.
The G6PD Antibody market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global G6PD Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the G6PD Antibody companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
IBL
GeneTex
Aviva Systems Biology
LifeSpan BioSciences
RayBiotech
NSJ Bioreagents
ProSci
Abnova Corporation
Bethyl Laboratories
Cell Signaling Technology
Leading Biology
Thermo Fisher Scientific
OriGene Technologies
ABclonal Technology
Proteintech Group
Sino Biological
Abcam
United States Biological
Biobyt
Jingjie PTM BioLab
Wuhan Fine
Segment by Type
Monoclonal
Polyclonal
Segment by Application
Immunochemistry (IHC)
Immunofluorescence (IF)
Immunoprecipitation (IP)
Western Blot (WB)
ELISA
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of G6PD Antibody company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global G6PD Antibody Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Monoclonal
1.2.3 Polyclonal
1.3 Market by Application
1.3.1 Global G6PD Antibody Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Immunochemistry (IHC)
1.3.3 Immunofluorescence (IF)
1.3.4 Immunoprecipitation (IP)
1.3.5 Western Blot (WB)
1.3.6 ELISA
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global G6PD Antibody Market Perspective (2020-2031)
2.2 Global G6PD Antibody Growth Trends by Region
2.2.1 Global G6PD Antibody Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 G6PD Antibody Historic Market Size by Region (2020-2025)
2.2.3 G6PD Antibody Forecasted Market Size by Region (2026-2031)
2.3 G6PD Antibody Market Dynamics
2.3.1 G6PD Antibody Industry Trends
2.3.2 G6PD Antibody Market Drivers
2.3.3 G6PD Antibody Market Challenges
2.3.4 G6PD Antibody Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top G6PD Antibody Players by Revenue
3.1.1 Global Top G6PD Antibody Players by Revenue (2020-2025)
3.1.2 Global G6PD Antibody Revenue Market Share by Players (2020-2025)
3.2 Global G6PD Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by G6PD Antibody Revenue
3.4 Global G6PD Antibody Market Concentration Ratio
3.4.1 Global G6PD Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by G6PD Antibody Revenue in 2024
3.5 Global Key Players of G6PD Antibody Head office and Area Served
3.6 Global Key Players of G6PD Antibody, Product and Application
3.7 Global Key Players of G6PD Antibody, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 G6PD Antibody Breakdown Data by Type
4.1 Global G6PD Antibody Historic Market Size by Type (2020-2025)
4.2 Global G6PD Antibody Forecasted Market Size by Type (2026-2031)
5 G6PD Antibody Breakdown Data by Application
5.1 Global G6PD Antibody Historic Market Size by Application (2020-2025)
5.2 Global G6PD Antibody Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America G6PD Antibody Market Size (2020-2031)
6.2 North America G6PD Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America G6PD Antibody Market Size by Country (2020-2025)
6.4 North America G6PD Antibody Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe G6PD Antibody Market Size (2020-2031)
7.2 Europe G6PD Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe G6PD Antibody Market Size by Country (2020-2025)
7.4 Europe G6PD Antibody Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific G6PD Antibody Market Size (2020-2031)
8.2 Asia-Pacific G6PD Antibody Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific G6PD Antibody Market Size by Region (2020-2025)
8.4 Asia-Pacific G6PD Antibody Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America G6PD Antibody Market Size (2020-2031)
9.2 Latin America G6PD Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America G6PD Antibody Market Size by Country (2020-2025)
9.4 Latin America G6PD Antibody Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa G6PD Antibody Market Size (2020-2031)
10.2 Middle East & Africa G6PD Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa G6PD Antibody Market Size by Country (2020-2025)
10.4 Middle East & Africa G6PD Antibody Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck G6PD Antibody Introduction
11.1.4 Merck Revenue in G6PD Antibody Business (2020-2025)
11.1.5 Merck Recent Development
11.2 IBL
11.2.1 IBL Company Details
11.2.2 IBL Business Overview
11.2.3 IBL G6PD Antibody Introduction
11.2.4 IBL Revenue in G6PD Antibody Business (2020-2025)
11.2.5 IBL Recent Development
11.3 GeneTex
11.3.1 GeneTex Company Details
11.3.2 GeneTex Business Overview
11.3.3 GeneTex G6PD Antibody Introduction
11.3.4 GeneTex Revenue in G6PD Antibody Business (2020-2025)
11.3.5 GeneTex Recent Development
11.4 Aviva Systems Biology
11.4.1 Aviva Systems Biology Company Details
11.4.2 Aviva Systems Biology Business Overview
11.4.3 Aviva Systems Biology G6PD Antibody Introduction
11.4.4 Aviva Systems Biology Revenue in G6PD Antibody Business (2020-2025)
11.4.5 Aviva Systems Biology Recent Development
11.5 LifeSpan BioSciences
11.5.1 LifeSpan BioSciences Company Details
11.5.2 LifeSpan BioSciences Business Overview
11.5.3 LifeSpan BioSciences G6PD Antibody Introduction
11.5.4 LifeSpan BioSciences Revenue in G6PD Antibody Business (2020-2025)
11.5.5 LifeSpan BioSciences Recent Development
11.6 RayBiotech
11.6.1 RayBiotech Company Details
11.6.2 RayBiotech Business Overview
11.6.3 RayBiotech G6PD Antibody Introduction
11.6.4 RayBiotech Revenue in G6PD Antibody Business (2020-2025)
11.6.5 RayBiotech Recent Development
11.7 NSJ Bioreagents
11.7.1 NSJ Bioreagents Company Details
11.7.2 NSJ Bioreagents Business Overview
11.7.3 NSJ Bioreagents G6PD Antibody Introduction
11.7.4 NSJ Bioreagents Revenue in G6PD Antibody Business (2020-2025)
11.7.5 NSJ Bioreagents Recent Development
11.8 ProSci
11.8.1 ProSci Company Details
11.8.2 ProSci Business Overview
11.8.3 ProSci G6PD Antibody Introduction
11.8.4 ProSci Revenue in G6PD Antibody Business (2020-2025)
11.8.5 ProSci Recent Development
11.9 Abnova Corporation
11.9.1 Abnova Corporation Company Details
11.9.2 Abnova Corporation Business Overview
11.9.3 Abnova Corporation G6PD Antibody Introduction
11.9.4 Abnova Corporation Revenue in G6PD Antibody Business (2020-2025)
11.9.5 Abnova Corporation Recent Development
11.10 Bethyl Laboratories
11.10.1 Bethyl Laboratories Company Details
11.10.2 Bethyl Laboratories Business Overview
11.10.3 Bethyl Laboratories G6PD Antibody Introduction
11.10.4 Bethyl Laboratories Revenue in G6PD Antibody Business (2020-2025)
11.10.5 Bethyl Laboratories Recent Development
11.11 Cell Signaling Technology
11.11.1 Cell Signaling Technology Company Details
11.11.2 Cell Signaling Technology Business Overview
11.11.3 Cell Signaling Technology G6PD Antibody Introduction
11.11.4 Cell Signaling Technology Revenue in G6PD Antibody Business (2020-2025)
11.11.5 Cell Signaling Technology Recent Development
11.12 Leading Biology
11.12.1 Leading Biology Company Details
11.12.2 Leading Biology Business Overview
11.12.3 Leading Biology G6PD Antibody Introduction
11.12.4 Leading Biology Revenue in G6PD Antibody Business (2020-2025)
11.12.5 Leading Biology Recent Development
11.13 Thermo Fisher Scientific
11.13.1 Thermo Fisher Scientific Company Details
11.13.2 Thermo Fisher Scientific Business Overview
11.13.3 Thermo Fisher Scientific G6PD Antibody Introduction
11.13.4 Thermo Fisher Scientific Revenue in G6PD Antibody Business (2020-2025)
11.13.5 Thermo Fisher Scientific Recent Development
11.14 OriGene Technologies
11.14.1 OriGene Technologies Company Details
11.14.2 OriGene Technologies Business Overview
11.14.3 OriGene Technologies G6PD Antibody Introduction
11.14.4 OriGene Technologies Revenue in G6PD Antibody Business (2020-2025)
11.14.5 OriGene Technologies Recent Development
11.15 ABclonal Technology
11.15.1 ABclonal Technology Company Details
11.15.2 ABclonal Technology Business Overview
11.15.3 ABclonal Technology G6PD Antibody Introduction
11.15.4 ABclonal Technology Revenue in G6PD Antibody Business (2020-2025)
11.15.5 ABclonal Technology Recent Development
11.16 Proteintech Group
11.16.1 Proteintech Group Company Details
11.16.2 Proteintech Group Business Overview
11.16.3 Proteintech Group G6PD Antibody Introduction
11.16.4 Proteintech Group Revenue in G6PD Antibody Business (2020-2025)
11.16.5 Proteintech Group Recent Development
11.17 Sino Biological
11.17.1 Sino Biological Company Details
11.17.2 Sino Biological Business Overview
11.17.3 Sino Biological G6PD Antibody Introduction
11.17.4 Sino Biological Revenue in G6PD Antibody Business (2020-2025)
11.17.5 Sino Biological Recent Development
11.18 Abcam
11.18.1 Abcam Company Details
11.18.2 Abcam Business Overview
11.18.3 Abcam G6PD Antibody Introduction
11.18.4 Abcam Revenue in G6PD Antibody Business (2020-2025)
11.18.5 Abcam Recent Development
11.19 United States Biological
11.19.1 United States Biological Company Details
11.19.2 United States Biological Business Overview
11.19.3 United States Biological G6PD Antibody Introduction
11.19.4 United States Biological Revenue in G6PD Antibody Business (2020-2025)
11.19.5 United States Biological Recent Development
11.20 Biobyt
11.20.1 Biobyt Company Details
11.20.2 Biobyt Business Overview
11.20.3 Biobyt G6PD Antibody Introduction
11.20.4 Biobyt Revenue in G6PD Antibody Business (2020-2025)
11.20.5 Biobyt Recent Development
11.21 Jingjie PTM BioLab
11.21.1 Jingjie PTM BioLab Company Details
11.21.2 Jingjie PTM BioLab Business Overview
11.21.3 Jingjie PTM BioLab G6PD Antibody Introduction
11.21.4 Jingjie PTM BioLab Revenue in G6PD Antibody Business (2020-2025)
11.21.5 Jingjie PTM BioLab Recent Development
11.22 Wuhan Fine
11.22.1 Wuhan Fine Company Details
11.22.2 Wuhan Fine Business Overview
11.22.3 Wuhan Fine G6PD Antibody Introduction
11.22.4 Wuhan Fine Revenue in G6PD Antibody Business (2020-2025)
11.22.5 Wuhan Fine Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global G6PD Antibody Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Monoclonal
1.2.3 Polyclonal
1.3 Market by Application
1.3.1 Global G6PD Antibody Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Immunochemistry (IHC)
1.3.3 Immunofluorescence (IF)
1.3.4 Immunoprecipitation (IP)
1.3.5 Western Blot (WB)
1.3.6 ELISA
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global G6PD Antibody Market Perspective (2020-2031)
2.2 Global G6PD Antibody Growth Trends by Region
2.2.1 Global G6PD Antibody Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 G6PD Antibody Historic Market Size by Region (2020-2025)
2.2.3 G6PD Antibody Forecasted Market Size by Region (2026-2031)
2.3 G6PD Antibody Market Dynamics
2.3.1 G6PD Antibody Industry Trends
2.3.2 G6PD Antibody Market Drivers
2.3.3 G6PD Antibody Market Challenges
2.3.4 G6PD Antibody Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top G6PD Antibody Players by Revenue
3.1.1 Global Top G6PD Antibody Players by Revenue (2020-2025)
3.1.2 Global G6PD Antibody Revenue Market Share by Players (2020-2025)
3.2 Global G6PD Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by G6PD Antibody Revenue
3.4 Global G6PD Antibody Market Concentration Ratio
3.4.1 Global G6PD Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by G6PD Antibody Revenue in 2024
3.5 Global Key Players of G6PD Antibody Head office and Area Served
3.6 Global Key Players of G6PD Antibody, Product and Application
3.7 Global Key Players of G6PD Antibody, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 G6PD Antibody Breakdown Data by Type
4.1 Global G6PD Antibody Historic Market Size by Type (2020-2025)
4.2 Global G6PD Antibody Forecasted Market Size by Type (2026-2031)
5 G6PD Antibody Breakdown Data by Application
5.1 Global G6PD Antibody Historic Market Size by Application (2020-2025)
5.2 Global G6PD Antibody Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America G6PD Antibody Market Size (2020-2031)
6.2 North America G6PD Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America G6PD Antibody Market Size by Country (2020-2025)
6.4 North America G6PD Antibody Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe G6PD Antibody Market Size (2020-2031)
7.2 Europe G6PD Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe G6PD Antibody Market Size by Country (2020-2025)
7.4 Europe G6PD Antibody Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific G6PD Antibody Market Size (2020-2031)
8.2 Asia-Pacific G6PD Antibody Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific G6PD Antibody Market Size by Region (2020-2025)
8.4 Asia-Pacific G6PD Antibody Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America G6PD Antibody Market Size (2020-2031)
9.2 Latin America G6PD Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America G6PD Antibody Market Size by Country (2020-2025)
9.4 Latin America G6PD Antibody Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa G6PD Antibody Market Size (2020-2031)
10.2 Middle East & Africa G6PD Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa G6PD Antibody Market Size by Country (2020-2025)
10.4 Middle East & Africa G6PD Antibody Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck G6PD Antibody Introduction
11.1.4 Merck Revenue in G6PD Antibody Business (2020-2025)
11.1.5 Merck Recent Development
11.2 IBL
11.2.1 IBL Company Details
11.2.2 IBL Business Overview
11.2.3 IBL G6PD Antibody Introduction
11.2.4 IBL Revenue in G6PD Antibody Business (2020-2025)
11.2.5 IBL Recent Development
11.3 GeneTex
11.3.1 GeneTex Company Details
11.3.2 GeneTex Business Overview
11.3.3 GeneTex G6PD Antibody Introduction
11.3.4 GeneTex Revenue in G6PD Antibody Business (2020-2025)
11.3.5 GeneTex Recent Development
11.4 Aviva Systems Biology
11.4.1 Aviva Systems Biology Company Details
11.4.2 Aviva Systems Biology Business Overview
11.4.3 Aviva Systems Biology G6PD Antibody Introduction
11.4.4 Aviva Systems Biology Revenue in G6PD Antibody Business (2020-2025)
11.4.5 Aviva Systems Biology Recent Development
11.5 LifeSpan BioSciences
11.5.1 LifeSpan BioSciences Company Details
11.5.2 LifeSpan BioSciences Business Overview
11.5.3 LifeSpan BioSciences G6PD Antibody Introduction
11.5.4 LifeSpan BioSciences Revenue in G6PD Antibody Business (2020-2025)
11.5.5 LifeSpan BioSciences Recent Development
11.6 RayBiotech
11.6.1 RayBiotech Company Details
11.6.2 RayBiotech Business Overview
11.6.3 RayBiotech G6PD Antibody Introduction
11.6.4 RayBiotech Revenue in G6PD Antibody Business (2020-2025)
11.6.5 RayBiotech Recent Development
11.7 NSJ Bioreagents
11.7.1 NSJ Bioreagents Company Details
11.7.2 NSJ Bioreagents Business Overview
11.7.3 NSJ Bioreagents G6PD Antibody Introduction
11.7.4 NSJ Bioreagents Revenue in G6PD Antibody Business (2020-2025)
11.7.5 NSJ Bioreagents Recent Development
11.8 ProSci
11.8.1 ProSci Company Details
11.8.2 ProSci Business Overview
11.8.3 ProSci G6PD Antibody Introduction
11.8.4 ProSci Revenue in G6PD Antibody Business (2020-2025)
11.8.5 ProSci Recent Development
11.9 Abnova Corporation
11.9.1 Abnova Corporation Company Details
11.9.2 Abnova Corporation Business Overview
11.9.3 Abnova Corporation G6PD Antibody Introduction
11.9.4 Abnova Corporation Revenue in G6PD Antibody Business (2020-2025)
11.9.5 Abnova Corporation Recent Development
11.10 Bethyl Laboratories
11.10.1 Bethyl Laboratories Company Details
11.10.2 Bethyl Laboratories Business Overview
11.10.3 Bethyl Laboratories G6PD Antibody Introduction
11.10.4 Bethyl Laboratories Revenue in G6PD Antibody Business (2020-2025)
11.10.5 Bethyl Laboratories Recent Development
11.11 Cell Signaling Technology
11.11.1 Cell Signaling Technology Company Details
11.11.2 Cell Signaling Technology Business Overview
11.11.3 Cell Signaling Technology G6PD Antibody Introduction
11.11.4 Cell Signaling Technology Revenue in G6PD Antibody Business (2020-2025)
11.11.5 Cell Signaling Technology Recent Development
11.12 Leading Biology
11.12.1 Leading Biology Company Details
11.12.2 Leading Biology Business Overview
11.12.3 Leading Biology G6PD Antibody Introduction
11.12.4 Leading Biology Revenue in G6PD Antibody Business (2020-2025)
11.12.5 Leading Biology Recent Development
11.13 Thermo Fisher Scientific
11.13.1 Thermo Fisher Scientific Company Details
11.13.2 Thermo Fisher Scientific Business Overview
11.13.3 Thermo Fisher Scientific G6PD Antibody Introduction
11.13.4 Thermo Fisher Scientific Revenue in G6PD Antibody Business (2020-2025)
11.13.5 Thermo Fisher Scientific Recent Development
11.14 OriGene Technologies
11.14.1 OriGene Technologies Company Details
11.14.2 OriGene Technologies Business Overview
11.14.3 OriGene Technologies G6PD Antibody Introduction
11.14.4 OriGene Technologies Revenue in G6PD Antibody Business (2020-2025)
11.14.5 OriGene Technologies Recent Development
11.15 ABclonal Technology
11.15.1 ABclonal Technology Company Details
11.15.2 ABclonal Technology Business Overview
11.15.3 ABclonal Technology G6PD Antibody Introduction
11.15.4 ABclonal Technology Revenue in G6PD Antibody Business (2020-2025)
11.15.5 ABclonal Technology Recent Development
11.16 Proteintech Group
11.16.1 Proteintech Group Company Details
11.16.2 Proteintech Group Business Overview
11.16.3 Proteintech Group G6PD Antibody Introduction
11.16.4 Proteintech Group Revenue in G6PD Antibody Business (2020-2025)
11.16.5 Proteintech Group Recent Development
11.17 Sino Biological
11.17.1 Sino Biological Company Details
11.17.2 Sino Biological Business Overview
11.17.3 Sino Biological G6PD Antibody Introduction
11.17.4 Sino Biological Revenue in G6PD Antibody Business (2020-2025)
11.17.5 Sino Biological Recent Development
11.18 Abcam
11.18.1 Abcam Company Details
11.18.2 Abcam Business Overview
11.18.3 Abcam G6PD Antibody Introduction
11.18.4 Abcam Revenue in G6PD Antibody Business (2020-2025)
11.18.5 Abcam Recent Development
11.19 United States Biological
11.19.1 United States Biological Company Details
11.19.2 United States Biological Business Overview
11.19.3 United States Biological G6PD Antibody Introduction
11.19.4 United States Biological Revenue in G6PD Antibody Business (2020-2025)
11.19.5 United States Biological Recent Development
11.20 Biobyt
11.20.1 Biobyt Company Details
11.20.2 Biobyt Business Overview
11.20.3 Biobyt G6PD Antibody Introduction
11.20.4 Biobyt Revenue in G6PD Antibody Business (2020-2025)
11.20.5 Biobyt Recent Development
11.21 Jingjie PTM BioLab
11.21.1 Jingjie PTM BioLab Company Details
11.21.2 Jingjie PTM BioLab Business Overview
11.21.3 Jingjie PTM BioLab G6PD Antibody Introduction
11.21.4 Jingjie PTM BioLab Revenue in G6PD Antibody Business (2020-2025)
11.21.5 Jingjie PTM BioLab Recent Development
11.22 Wuhan Fine
11.22.1 Wuhan Fine Company Details
11.22.2 Wuhan Fine Business Overview
11.22.3 Wuhan Fine G6PD Antibody Introduction
11.22.4 Wuhan Fine Revenue in G6PD Antibody Business (2020-2025)
11.22.5 Wuhan Fine Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global G6PD Antibody Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Monoclonal
Table 3. Key Players of Polyclonal
Table 4. Global G6PD Antibody Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global G6PD Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global G6PD Antibody Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global G6PD Antibody Market Share by Region (2020-2025)
Table 8. Global G6PD Antibody Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global G6PD Antibody Market Share by Region (2026-2031)
Table 10. G6PD Antibody Market Trends
Table 11. G6PD Antibody Market Drivers
Table 12. G6PD Antibody Market Challenges
Table 13. G6PD Antibody Market Restraints
Table 14. Global G6PD Antibody Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global G6PD Antibody Market Share by Players (2020-2025)
Table 16. Global Top G6PD Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in G6PD Antibody as of 2024)
Table 17. Ranking of Global Top G6PD Antibody Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by G6PD Antibody Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of G6PD Antibody, Headquarters and Area Served
Table 20. Global Key Players of G6PD Antibody, Product and Application
Table 21. Global Key Players of G6PD Antibody, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global G6PD Antibody Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global G6PD Antibody Revenue Market Share by Type (2020-2025)
Table 25. Global G6PD Antibody Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global G6PD Antibody Revenue Market Share by Type (2026-2031)
Table 27. Global G6PD Antibody Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global G6PD Antibody Revenue Market Share by Application (2020-2025)
Table 29. Global G6PD Antibody Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global G6PD Antibody Revenue Market Share by Application (2026-2031)
Table 31. North America G6PD Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America G6PD Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America G6PD Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe G6PD Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe G6PD Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe G6PD Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific G6PD Antibody Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific G6PD Antibody Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific G6PD Antibody Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America G6PD Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America G6PD Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America G6PD Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa G6PD Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa G6PD Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa G6PD Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 46. Merck Company Details
Table 47. Merck Business Overview
Table 48. Merck G6PD Antibody Product
Table 49. Merck Revenue in G6PD Antibody Business (2020-2025) & (US$ Million)
Table 50. Merck Recent Development
Table 51. IBL Company Details
Table 52. IBL Business Overview
Table 53. IBL G6PD Antibody Product
Table 54. IBL Revenue in G6PD Antibody Business (2020-2025) & (US$ Million)
Table 55. IBL Recent Development
Table 56. GeneTex Company Details
Table 57. GeneTex Business Overview
Table 58. GeneTex G6PD Antibody Product
Table 59. GeneTex Revenue in G6PD Antibody Business (2020-2025) & (US$ Million)
Table 60. GeneTex Recent Development
Table 61. Aviva Systems Biology Company Details
Table 62. Aviva Systems Biology Business Overview
Table 63. Aviva Systems Biology G6PD Antibody Product
Table 64. Aviva Systems Biology Revenue in G6PD Antibody Business (2020-2025) & (US$ Million)
Table 65. Aviva Systems Biology Recent Development
Table 66. LifeSpan BioSciences Company Details
Table 67. LifeSpan BioSciences Business Overview
Table 68. LifeSpan BioSciences G6PD Antibody Product
Table 69. LifeSpan BioSciences Revenue in G6PD Antibody Business (2020-2025) & (US$ Million)
Table 70. LifeSpan BioSciences Recent Development
Table 71. RayBiotech Company Details
Table 72. RayBiotech Business Overview
Table 73. RayBiotech G6PD Antibody Product
Table 74. RayBiotech Revenue in G6PD Antibody Business (2020-2025) & (US$ Million)
Table 75. RayBiotech Recent Development
Table 76. NSJ Bioreagents Company Details
Table 77. NSJ Bioreagents Business Overview
Table 78. NSJ Bioreagents G6PD Antibody Product
Table 79. NSJ Bioreagents Revenue in G6PD Antibody Business (2020-2025) & (US$ Million)
Table 80. NSJ Bioreagents Recent Development
Table 81. ProSci Company Details
Table 82. ProSci Business Overview
Table 83. ProSci G6PD Antibody Product
Table 84. ProSci Revenue in G6PD Antibody Business (2020-2025) & (US$ Million)
Table 85. ProSci Recent Development
Table 86. Abnova Corporation Company Details
Table 87. Abnova Corporation Business Overview
Table 88. Abnova Corporation G6PD Antibody Product
Table 89. Abnova Corporation Revenue in G6PD Antibody Business (2020-2025) & (US$ Million)
Table 90. Abnova Corporation Recent Development
Table 91. Bethyl Laboratories Company Details
Table 92. Bethyl Laboratories Business Overview
Table 93. Bethyl Laboratories G6PD Antibody Product
Table 94. Bethyl Laboratories Revenue in G6PD Antibody Business (2020-2025) & (US$ Million)
Table 95. Bethyl Laboratories Recent Development
Table 96. Cell Signaling Technology Company Details
Table 97. Cell Signaling Technology Business Overview
Table 98. Cell Signaling Technology G6PD Antibody Product
Table 99. Cell Signaling Technology Revenue in G6PD Antibody Business (2020-2025) & (US$ Million)
Table 100. Cell Signaling Technology Recent Development
Table 101. Leading Biology Company Details
Table 102. Leading Biology Business Overview
Table 103. Leading Biology G6PD Antibody Product
Table 104. Leading Biology Revenue in G6PD Antibody Business (2020-2025) & (US$ Million)
Table 105. Leading Biology Recent Development
Table 106. Thermo Fisher Scientific Company Details
Table 107. Thermo Fisher Scientific Business Overview
Table 108. Thermo Fisher Scientific G6PD Antibody Product
Table 109. Thermo Fisher Scientific Revenue in G6PD Antibody Business (2020-2025) & (US$ Million)
Table 110. Thermo Fisher Scientific Recent Development
Table 111. OriGene Technologies Company Details
Table 112. OriGene Technologies Business Overview
Table 113. OriGene Technologies G6PD Antibody Product
Table 114. OriGene Technologies Revenue in G6PD Antibody Business (2020-2025) & (US$ Million)
Table 115. OriGene Technologies Recent Development
Table 116. ABclonal Technology Company Details
Table 117. ABclonal Technology Business Overview
Table 118. ABclonal Technology G6PD Antibody Product
Table 119. ABclonal Technology Revenue in G6PD Antibody Business (2020-2025) & (US$ Million)
Table 120. ABclonal Technology Recent Development
Table 121. Proteintech Group Company Details
Table 122. Proteintech Group Business Overview
Table 123. Proteintech Group G6PD Antibody Product
Table 124. Proteintech Group Revenue in G6PD Antibody Business (2020-2025) & (US$ Million)
Table 125. Proteintech Group Recent Development
Table 126. Sino Biological Company Details
Table 127. Sino Biological Business Overview
Table 128. Sino Biological G6PD Antibody Product
Table 129. Sino Biological Revenue in G6PD Antibody Business (2020-2025) & (US$ Million)
Table 130. Sino Biological Recent Development
Table 131. Abcam Company Details
Table 132. Abcam Business Overview
Table 133. Abcam G6PD Antibody Product
Table 134. Abcam Revenue in G6PD Antibody Business (2020-2025) & (US$ Million)
Table 135. Abcam Recent Development
Table 136. United States Biological Company Details
Table 137. United States Biological Business Overview
Table 138. United States Biological G6PD Antibody Product
Table 139. United States Biological Revenue in G6PD Antibody Business (2020-2025) & (US$ Million)
Table 140. United States Biological Recent Development
Table 141. Biobyt Company Details
Table 142. Biobyt Business Overview
Table 143. Biobyt G6PD Antibody Product
Table 144. Biobyt Revenue in G6PD Antibody Business (2020-2025) & (US$ Million)
Table 145. Biobyt Recent Development
Table 146. Jingjie PTM BioLab Company Details
Table 147. Jingjie PTM BioLab Business Overview
Table 148. Jingjie PTM BioLab G6PD Antibody Product
Table 149. Jingjie PTM BioLab Revenue in G6PD Antibody Business (2020-2025) & (US$ Million)
Table 150. Jingjie PTM BioLab Recent Development
Table 151. Wuhan Fine Company Details
Table 152. Wuhan Fine Business Overview
Table 153. Wuhan Fine G6PD Antibody Product
Table 154. Wuhan Fine Revenue in G6PD Antibody Business (2020-2025) & (US$ Million)
Table 155. Wuhan Fine Recent Development
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
Table 159. Authors List of This Report
List of Figures
Figure 1. G6PD Antibody Picture
Figure 2. Global G6PD Antibody Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global G6PD Antibody Market Share by Type: 2024 VS 2031
Figure 4. Monoclonal Features
Figure 5. Polyclonal Features
Figure 6. Global G6PD Antibody Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global G6PD Antibody Market Share by Application: 2024 VS 2031
Figure 8. Immunochemistry (IHC) Case Studies
Figure 9. Immunofluorescence (IF) Case Studies
Figure 10. Immunoprecipitation (IP) Case Studies
Figure 11. Western Blot (WB) Case Studies
Figure 12. ELISA Case Studies
Figure 13. Others Case Studies
Figure 14. G6PD Antibody Report Years Considered
Figure 15. Global G6PD Antibody Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global G6PD Antibody Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global G6PD Antibody Market Share by Region: 2024 VS 2031
Figure 18. Global G6PD Antibody Market Share by Players in 2024
Figure 19. Global Top G6PD Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in G6PD Antibody as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by G6PD Antibody Revenue in 2024
Figure 21. North America G6PD Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America G6PD Antibody Market Share by Country (2020-2031)
Figure 23. United States G6PD Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada G6PD Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe G6PD Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe G6PD Antibody Market Share by Country (2020-2031)
Figure 27. Germany G6PD Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France G6PD Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. G6PD Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy G6PD Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia G6PD Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries G6PD Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific G6PD Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific G6PD Antibody Market Share by Region (2020-2031)
Figure 35. China G6PD Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan G6PD Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea G6PD Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia G6PD Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India G6PD Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia G6PD Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America G6PD Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America G6PD Antibody Market Share by Country (2020-2031)
Figure 43. Mexico G6PD Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil G6PD Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa G6PD Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa G6PD Antibody Market Share by Country (2020-2031)
Figure 47. Turkey G6PD Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia G6PD Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE G6PD Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Merck Revenue Growth Rate in G6PD Antibody Business (2020-2025)
Figure 51. IBL Revenue Growth Rate in G6PD Antibody Business (2020-2025)
Figure 52. GeneTex Revenue Growth Rate in G6PD Antibody Business (2020-2025)
Figure 53. Aviva Systems Biology Revenue Growth Rate in G6PD Antibody Business (2020-2025)
Figure 54. LifeSpan BioSciences Revenue Growth Rate in G6PD Antibody Business (2020-2025)
Figure 55. RayBiotech Revenue Growth Rate in G6PD Antibody Business (2020-2025)
Figure 56. NSJ Bioreagents Revenue Growth Rate in G6PD Antibody Business (2020-2025)
Figure 57. ProSci Revenue Growth Rate in G6PD Antibody Business (2020-2025)
Figure 58. Abnova Corporation Revenue Growth Rate in G6PD Antibody Business (2020-2025)
Figure 59. Bethyl Laboratories Revenue Growth Rate in G6PD Antibody Business (2020-2025)
Figure 60. Cell Signaling Technology Revenue Growth Rate in G6PD Antibody Business (2020-2025)
Figure 61. Leading Biology Revenue Growth Rate in G6PD Antibody Business (2020-2025)
Figure 62. Thermo Fisher Scientific Revenue Growth Rate in G6PD Antibody Business (2020-2025)
Figure 63. OriGene Technologies Revenue Growth Rate in G6PD Antibody Business (2020-2025)
Figure 64. ABclonal Technology Revenue Growth Rate in G6PD Antibody Business (2020-2025)
Figure 65. Proteintech Group Revenue Growth Rate in G6PD Antibody Business (2020-2025)
Figure 66. Sino Biological Revenue Growth Rate in G6PD Antibody Business (2020-2025)
Figure 67. Abcam Revenue Growth Rate in G6PD Antibody Business (2020-2025)
Figure 68. United States Biological Revenue Growth Rate in G6PD Antibody Business (2020-2025)
Figure 69. Biobyt Revenue Growth Rate in G6PD Antibody Business (2020-2025)
Figure 70. Jingjie PTM BioLab Revenue Growth Rate in G6PD Antibody Business (2020-2025)
Figure 71. Wuhan Fine Revenue Growth Rate in G6PD Antibody Business (2020-2025)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
Table 1. Global G6PD Antibody Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Monoclonal
Table 3. Key Players of Polyclonal
Table 4. Global G6PD Antibody Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global G6PD Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global G6PD Antibody Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global G6PD Antibody Market Share by Region (2020-2025)
Table 8. Global G6PD Antibody Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global G6PD Antibody Market Share by Region (2026-2031)
Table 10. G6PD Antibody Market Trends
Table 11. G6PD Antibody Market Drivers
Table 12. G6PD Antibody Market Challenges
Table 13. G6PD Antibody Market Restraints
Table 14. Global G6PD Antibody Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global G6PD Antibody Market Share by Players (2020-2025)
Table 16. Global Top G6PD Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in G6PD Antibody as of 2024)
Table 17. Ranking of Global Top G6PD Antibody Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by G6PD Antibody Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of G6PD Antibody, Headquarters and Area Served
Table 20. Global Key Players of G6PD Antibody, Product and Application
Table 21. Global Key Players of G6PD Antibody, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global G6PD Antibody Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global G6PD Antibody Revenue Market Share by Type (2020-2025)
Table 25. Global G6PD Antibody Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global G6PD Antibody Revenue Market Share by Type (2026-2031)
Table 27. Global G6PD Antibody Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global G6PD Antibody Revenue Market Share by Application (2020-2025)
Table 29. Global G6PD Antibody Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global G6PD Antibody Revenue Market Share by Application (2026-2031)
Table 31. North America G6PD Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America G6PD Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America G6PD Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe G6PD Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe G6PD Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe G6PD Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific G6PD Antibody Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific G6PD Antibody Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific G6PD Antibody Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America G6PD Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America G6PD Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America G6PD Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa G6PD Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa G6PD Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa G6PD Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 46. Merck Company Details
Table 47. Merck Business Overview
Table 48. Merck G6PD Antibody Product
Table 49. Merck Revenue in G6PD Antibody Business (2020-2025) & (US$ Million)
Table 50. Merck Recent Development
Table 51. IBL Company Details
Table 52. IBL Business Overview
Table 53. IBL G6PD Antibody Product
Table 54. IBL Revenue in G6PD Antibody Business (2020-2025) & (US$ Million)
Table 55. IBL Recent Development
Table 56. GeneTex Company Details
Table 57. GeneTex Business Overview
Table 58. GeneTex G6PD Antibody Product
Table 59. GeneTex Revenue in G6PD Antibody Business (2020-2025) & (US$ Million)
Table 60. GeneTex Recent Development
Table 61. Aviva Systems Biology Company Details
Table 62. Aviva Systems Biology Business Overview
Table 63. Aviva Systems Biology G6PD Antibody Product
Table 64. Aviva Systems Biology Revenue in G6PD Antibody Business (2020-2025) & (US$ Million)
Table 65. Aviva Systems Biology Recent Development
Table 66. LifeSpan BioSciences Company Details
Table 67. LifeSpan BioSciences Business Overview
Table 68. LifeSpan BioSciences G6PD Antibody Product
Table 69. LifeSpan BioSciences Revenue in G6PD Antibody Business (2020-2025) & (US$ Million)
Table 70. LifeSpan BioSciences Recent Development
Table 71. RayBiotech Company Details
Table 72. RayBiotech Business Overview
Table 73. RayBiotech G6PD Antibody Product
Table 74. RayBiotech Revenue in G6PD Antibody Business (2020-2025) & (US$ Million)
Table 75. RayBiotech Recent Development
Table 76. NSJ Bioreagents Company Details
Table 77. NSJ Bioreagents Business Overview
Table 78. NSJ Bioreagents G6PD Antibody Product
Table 79. NSJ Bioreagents Revenue in G6PD Antibody Business (2020-2025) & (US$ Million)
Table 80. NSJ Bioreagents Recent Development
Table 81. ProSci Company Details
Table 82. ProSci Business Overview
Table 83. ProSci G6PD Antibody Product
Table 84. ProSci Revenue in G6PD Antibody Business (2020-2025) & (US$ Million)
Table 85. ProSci Recent Development
Table 86. Abnova Corporation Company Details
Table 87. Abnova Corporation Business Overview
Table 88. Abnova Corporation G6PD Antibody Product
Table 89. Abnova Corporation Revenue in G6PD Antibody Business (2020-2025) & (US$ Million)
Table 90. Abnova Corporation Recent Development
Table 91. Bethyl Laboratories Company Details
Table 92. Bethyl Laboratories Business Overview
Table 93. Bethyl Laboratories G6PD Antibody Product
Table 94. Bethyl Laboratories Revenue in G6PD Antibody Business (2020-2025) & (US$ Million)
Table 95. Bethyl Laboratories Recent Development
Table 96. Cell Signaling Technology Company Details
Table 97. Cell Signaling Technology Business Overview
Table 98. Cell Signaling Technology G6PD Antibody Product
Table 99. Cell Signaling Technology Revenue in G6PD Antibody Business (2020-2025) & (US$ Million)
Table 100. Cell Signaling Technology Recent Development
Table 101. Leading Biology Company Details
Table 102. Leading Biology Business Overview
Table 103. Leading Biology G6PD Antibody Product
Table 104. Leading Biology Revenue in G6PD Antibody Business (2020-2025) & (US$ Million)
Table 105. Leading Biology Recent Development
Table 106. Thermo Fisher Scientific Company Details
Table 107. Thermo Fisher Scientific Business Overview
Table 108. Thermo Fisher Scientific G6PD Antibody Product
Table 109. Thermo Fisher Scientific Revenue in G6PD Antibody Business (2020-2025) & (US$ Million)
Table 110. Thermo Fisher Scientific Recent Development
Table 111. OriGene Technologies Company Details
Table 112. OriGene Technologies Business Overview
Table 113. OriGene Technologies G6PD Antibody Product
Table 114. OriGene Technologies Revenue in G6PD Antibody Business (2020-2025) & (US$ Million)
Table 115. OriGene Technologies Recent Development
Table 116. ABclonal Technology Company Details
Table 117. ABclonal Technology Business Overview
Table 118. ABclonal Technology G6PD Antibody Product
Table 119. ABclonal Technology Revenue in G6PD Antibody Business (2020-2025) & (US$ Million)
Table 120. ABclonal Technology Recent Development
Table 121. Proteintech Group Company Details
Table 122. Proteintech Group Business Overview
Table 123. Proteintech Group G6PD Antibody Product
Table 124. Proteintech Group Revenue in G6PD Antibody Business (2020-2025) & (US$ Million)
Table 125. Proteintech Group Recent Development
Table 126. Sino Biological Company Details
Table 127. Sino Biological Business Overview
Table 128. Sino Biological G6PD Antibody Product
Table 129. Sino Biological Revenue in G6PD Antibody Business (2020-2025) & (US$ Million)
Table 130. Sino Biological Recent Development
Table 131. Abcam Company Details
Table 132. Abcam Business Overview
Table 133. Abcam G6PD Antibody Product
Table 134. Abcam Revenue in G6PD Antibody Business (2020-2025) & (US$ Million)
Table 135. Abcam Recent Development
Table 136. United States Biological Company Details
Table 137. United States Biological Business Overview
Table 138. United States Biological G6PD Antibody Product
Table 139. United States Biological Revenue in G6PD Antibody Business (2020-2025) & (US$ Million)
Table 140. United States Biological Recent Development
Table 141. Biobyt Company Details
Table 142. Biobyt Business Overview
Table 143. Biobyt G6PD Antibody Product
Table 144. Biobyt Revenue in G6PD Antibody Business (2020-2025) & (US$ Million)
Table 145. Biobyt Recent Development
Table 146. Jingjie PTM BioLab Company Details
Table 147. Jingjie PTM BioLab Business Overview
Table 148. Jingjie PTM BioLab G6PD Antibody Product
Table 149. Jingjie PTM BioLab Revenue in G6PD Antibody Business (2020-2025) & (US$ Million)
Table 150. Jingjie PTM BioLab Recent Development
Table 151. Wuhan Fine Company Details
Table 152. Wuhan Fine Business Overview
Table 153. Wuhan Fine G6PD Antibody Product
Table 154. Wuhan Fine Revenue in G6PD Antibody Business (2020-2025) & (US$ Million)
Table 155. Wuhan Fine Recent Development
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
Table 159. Authors List of This Report
List of Figures
Figure 1. G6PD Antibody Picture
Figure 2. Global G6PD Antibody Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global G6PD Antibody Market Share by Type: 2024 VS 2031
Figure 4. Monoclonal Features
Figure 5. Polyclonal Features
Figure 6. Global G6PD Antibody Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global G6PD Antibody Market Share by Application: 2024 VS 2031
Figure 8. Immunochemistry (IHC) Case Studies
Figure 9. Immunofluorescence (IF) Case Studies
Figure 10. Immunoprecipitation (IP) Case Studies
Figure 11. Western Blot (WB) Case Studies
Figure 12. ELISA Case Studies
Figure 13. Others Case Studies
Figure 14. G6PD Antibody Report Years Considered
Figure 15. Global G6PD Antibody Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global G6PD Antibody Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global G6PD Antibody Market Share by Region: 2024 VS 2031
Figure 18. Global G6PD Antibody Market Share by Players in 2024
Figure 19. Global Top G6PD Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in G6PD Antibody as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by G6PD Antibody Revenue in 2024
Figure 21. North America G6PD Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America G6PD Antibody Market Share by Country (2020-2031)
Figure 23. United States G6PD Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada G6PD Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe G6PD Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe G6PD Antibody Market Share by Country (2020-2031)
Figure 27. Germany G6PD Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France G6PD Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. G6PD Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy G6PD Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia G6PD Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries G6PD Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific G6PD Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific G6PD Antibody Market Share by Region (2020-2031)
Figure 35. China G6PD Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan G6PD Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea G6PD Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia G6PD Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India G6PD Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia G6PD Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America G6PD Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America G6PD Antibody Market Share by Country (2020-2031)
Figure 43. Mexico G6PD Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil G6PD Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa G6PD Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa G6PD Antibody Market Share by Country (2020-2031)
Figure 47. Turkey G6PD Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia G6PD Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE G6PD Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Merck Revenue Growth Rate in G6PD Antibody Business (2020-2025)
Figure 51. IBL Revenue Growth Rate in G6PD Antibody Business (2020-2025)
Figure 52. GeneTex Revenue Growth Rate in G6PD Antibody Business (2020-2025)
Figure 53. Aviva Systems Biology Revenue Growth Rate in G6PD Antibody Business (2020-2025)
Figure 54. LifeSpan BioSciences Revenue Growth Rate in G6PD Antibody Business (2020-2025)
Figure 55. RayBiotech Revenue Growth Rate in G6PD Antibody Business (2020-2025)
Figure 56. NSJ Bioreagents Revenue Growth Rate in G6PD Antibody Business (2020-2025)
Figure 57. ProSci Revenue Growth Rate in G6PD Antibody Business (2020-2025)
Figure 58. Abnova Corporation Revenue Growth Rate in G6PD Antibody Business (2020-2025)
Figure 59. Bethyl Laboratories Revenue Growth Rate in G6PD Antibody Business (2020-2025)
Figure 60. Cell Signaling Technology Revenue Growth Rate in G6PD Antibody Business (2020-2025)
Figure 61. Leading Biology Revenue Growth Rate in G6PD Antibody Business (2020-2025)
Figure 62. Thermo Fisher Scientific Revenue Growth Rate in G6PD Antibody Business (2020-2025)
Figure 63. OriGene Technologies Revenue Growth Rate in G6PD Antibody Business (2020-2025)
Figure 64. ABclonal Technology Revenue Growth Rate in G6PD Antibody Business (2020-2025)
Figure 65. Proteintech Group Revenue Growth Rate in G6PD Antibody Business (2020-2025)
Figure 66. Sino Biological Revenue Growth Rate in G6PD Antibody Business (2020-2025)
Figure 67. Abcam Revenue Growth Rate in G6PD Antibody Business (2020-2025)
Figure 68. United States Biological Revenue Growth Rate in G6PD Antibody Business (2020-2025)
Figure 69. Biobyt Revenue Growth Rate in G6PD Antibody Business (2020-2025)
Figure 70. Jingjie PTM BioLab Revenue Growth Rate in G6PD Antibody Business (2020-2025)
Figure 71. Wuhan Fine Revenue Growth Rate in G6PD Antibody Business (2020-2025)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Electrolytes for Lithium-Ion Batteries Market Research Report 2025
Jul 14, 25
Global Vanadium Products Market Research Report 2025
Jul 14, 25
Global High-purity Vanadium Oxide Market Research Report 2025
Jul 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232